Related Experiment Video
Updated: Jul 16, 2026
08:47
Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
Drug carriers in pharmaceutical design: promises and progress
1ExCel-Matrix Biological Devices Pvt. Ltd., 12-5-149/16/2, Vijayapuri, South Lalaguda, Hyderabad, India. ranjna_dutta@rediffmail.com
Current Pharmaceutical Design
|March 10, 2007
Summary
Drug encapsulation in biocompatible carriers improves drug delivery and reduces side effects. This approach enhances therapeutic efficacy by protecting drugs and modulating immune responses for better treatment outcomes.
Area of Science:
- Drug delivery systems
- Nanotechnology in medicine
- Pharmacology
Background:
- Drug side effects are a significant challenge in medicine.
- Developing ideal drugs requires addressing toxicity and stability.
- Restoring physiological functions necessitates advanced therapeutic strategies.
Purpose of the Study:
- To review advancements in drug carriers and encapsulation technologies.
- To explore the impact of these technologies on the pharmaceutical industry.
- To highlight the potential of novel materials for drug encapsulation.
Main Methods:
- Review of current literature on drug encapsulation and carriers.
- Analysis of biocompatible materials for encapsulation (e.g., lipoproteins, dendrimers).
- Evaluation of strategies to incorporate immunomodulators for enhanced host response.
Main Results:
- Encapsulation protects toxic drugs and prolongs their half-life.
- Biocompatible nano/microspheres offer improved drug delivery.
- Incorporation of immunomodulators can strengthen host immune response against pathogens.
- Novel materials like fullerenes and dendrimers show promise for encapsulation.
Conclusions:
- Drug encapsulation is a promising strategy to overcome limitations of conventional drugs.
- This approach can lead to safer and more effective therapeutics.
- Further research into advanced drug carriers will significantly impact the therapeutic industry.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...